Stocks / NASDAQ / Aptose Biosciences, Inc.

Aptose Biosciences, Inc.

Our Opinion

Aptose Biosciences, Inc. is in the Cruelty Free Investing use of animals list because they exploit animals for product testing.

Additional resources:

Overview of APTO-253 in-vivo study.

Company Description

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy.